AI Daily Brief — 12 January 2026

JPM Healthcare kicks off with a $1B AI move. NVIDIA and Eli Lilly announce a five-year, $1B co-innovation lab in the SF Bay Area, built on BioNeMo + Vera Rubin, with new models for RNA structure, molecular synthesis and toxicity prediction. Torq closes a $140M Series D at a $1.2B valuation — AI SOC platform, Merlin Ventures-led with Evolution, Notable, Bessemer, Insight, Greenfield. Hippocratic AI acquires Grove AI for agentic pharma R&D / clinical-trial-ops. Shopify and Google co-author technical specs for the UCP agent-to-merchant handoff.

Top stories

• NVIDIA × Lilly — $1B drug-discovery lab. Five-year partnership, BioNeMo + Vera Rubin co-innovation; new models for RNA, molecular synthesis, toxicity. via NVIDIA
• Torq — $140M Series D at $1.2B. AI SOC platform; Merlin Ventures-led, Evolution / Notable / Bessemer / Insight / Greenfield joining. Total funding $332M; ~300% revenue growth in 2025. via Torq
• Hippocratic × Grove AI. Patient-facing healthcare-agent vendor Hippocratic acquires Grove AI for agentic pharma R&D / clinical-trial ops. via We Will Cure
• Shopify × Google co-author UCP specs. MediaPost details agent-to-merchant handoff technicals from Sunday’s NRF unveil. via MediaPost

Compiled by AI Feed’s editor from publicly reported announcements on 12 January 2026.